• Advancing Synaptic Transmission Research with CGP 55845 Hydr

  2026-07-27

  This thought-leadership article empowers translational neuroscientists to dissect GABAB-mediated synaptic mechanisms using CGP 55845 hydrochloride, a highly selective GABAB receptor antagonist. Integrating mechanistic insights from cutting-edge astrocyte research, it guides experimental design, highlights protocol best practices, and contextualizes the compound’s unique role in unraveling cognitive pathways within the dentate gyrus. The piece bridges recent glial discoveries with practical assay optimization and carves out new conceptual space beyond traditional product pages.

• Applied Workflows with EZ Cap™ Human PTEN mRNA (ψUTP) in Can

  2026-07-26

  EZ Cap™ Human PTEN mRNA (ψUTP) enables robust, immune-silent PTEN re-expression in mammalian systems, uniquely positioning it for translational oncology and drug resistance studies. Its pseudouridine modification and Cap 1 structure deliver superior mRNA stability and PI3K/Akt pathway inhibition, supporting reproducible, high-impact workflows in advanced cancer research.

• Rosiglitazone (Brl-49653): Precision Tools for Adipose Brown

  2026-07-25

  Explore the advanced applications of Rosiglitazone (Brl-49653) in adipose tissue browning and metabolic assay innovation. This article uniquely connects mechanistic insight with practical protocol choices, offering a new depth for type II diabetes research.

• p-Cresyl Sulfate Drives Aortic Valve Calcification via Kloth

  2026-07-24

  This study uncovers how p-cresyl sulfate, a uremic toxin, directly enhances calcification of aortic valvular interstitial cells by downregulating klotho and SIRT1 signaling. These findings provide mechanistic insight into cardiovascular risk in chronic kidney disease and highlight potential therapeutic targets for calcific aortic valve disease.

• Single-Dose Indometacin Sodium for Acute Postoperative Pain

  2026-07-24

  This Cochrane review rigorously evaluates the efficacy and safety of single-dose oral indometacin sodium for treating acute postoperative pain. The analysis provides critical quantitative insights into pain reduction outcomes, informing best practices for NSAID use in clinical pain management and experimental research.

• Vemurafenib in Melanoma: Mechanisms, Resistance, and Next St

  2026-07-23

  This thought-leadership article explores the mechanistic foundations and translational research strategies surrounding Vemurafenib (PLX4032, RG7204) in BRAF-mutant melanoma. Integrating multi-omics findings, it dissects resistance networks—especially ARID1A-driven adaptations—and provides protocol guidance for researchers seeking to model, dissect, and overcome therapeutic resistance in advanced melanoma.

• Novel 3-Dehydroteasterone Derivatives: Structure–Activity In

  2026-07-23

  This study introduces a new class of 3-dehydroteasterone derivatives featuring 23,24-dinorcholanic side chains and benzoate groups at C-22, systematically evaluating their plant growth regulatory activity. The findings clarify how specific structural modifications influence bioactivity in classical plant assays, advancing the rational design of brassinosteroid analogs for research.

• Cyanine 5-dCTP: Fluorescent Labeling for Advanced DNA Synthe

  2026-07-22

  Empower your DNA labeling and detection workflows with Cyanine 5-dCTP, a high-purity fluorescent nucleotide triphosphate optimized for enzymatic synthesis and imaging. Integrate this reagent to boost signal sensitivity, workflow efficiency, and experimental reproducibility across PCR, DNA sequencing, and advanced nucleic acid detection assays.

• BIBR 1532: Applied Telomerase Inhibitor Workflows & Optimiza

  2026-07-22

  BIBR 1532 enables precise and reproducible telomerase inhibition for advanced cancer research, including apoptosis induction and synergy studies. This guide distills experimental best practices, troubleshooting, and protocol enhancements to maximize data reliability and translational impact.

• AM251: Precision CB1 Receptor Antagonist for Cannabinoid Res

  2026-07-21

  AM251, available from APExBIO, enables unmatched selectivity and potency for dissecting CB1 receptor function in neuropharmacology, metabolic, and cell signaling studies. Its robust nanomolar affinity and well-characterized pharmacology empower advanced experimental workflows, especially when troubleshooting complex endocannabinoid mechanisms or modeling obesity.

• Practical Guide to Using the LDH Cytotoxicity Assay Kit (K22

  2026-07-21

  The LDH Cytotoxicity Assay Kit enables researchers to quantify cell damage and cytotoxicity by measuring lactate dehydrogenase release from compromised cell membranes. This non-radioactive kit is best used for bulk cell death assessment in cancer or neurodegenerative disease models, but is not suited for detailed mechanistic apoptosis analysis or subcellular localization studies.

• EZ Cap™ Cas9 mRNA (m1Ψ): Enhancing Genome Editing Precision

  2026-07-20

  EZ Cap™ Cas9 mRNA (m1Ψ) delivers superior mRNA stability, immune evasion, and translation efficiency for CRISPR-Cas9 genome editing in mammalian systems. Its Cap1 structure and m1Ψ modification minimize off-target effects and streamline experimental workflows, setting a new standard for high-fidelity, reproducible gene editing.

• Ajugol Mitigates Gouty Arthritis via PI3K/AKT/mTOR Inhibitio

  2026-07-20

  This study demonstrates that ajugol alleviates acute gouty arthritis by suppressing the PI3K/AKT/mTOR pathway, enhancing mitophagy, and reducing chondrocyte pyroptosis. The findings clarify the mechanistic basis for targeting mitochondrial homeostasis in inflammatory cartilage damage, with implications for translational research on regulated cell death.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Applicati

  2026-07-19

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody offers a reliable solution for sensitive, specific detection of goat IgG primary antibodies in fluorescence-based assays, including ICC/IF, IHC, flow cytometry, and ELISA. It should be used only as a secondary antibody for goat IgG detection, not for non-goat primaries or direct antigen labeling.

• Lumiracoxib: Selective COX-2 Inhibitor in Muscle Injury Assa

  2026-07-18

  Lumiracoxib empowers researchers with precision in dissecting inflammatory and vascular responses in muscle injury models, especially those involving tissue ischemia and regeneration. Its unique solubility profile and high COX-2 selectivity enable reproducible, high-sensitivity assays across complex workflows.

451 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page